All In MedTech

Device Trial Radar · NCT05633706

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

Evaluation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule for Small Intestinal Dysbiosis

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jan 9, 2023

Primary completion

Jun 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Nimble Science Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Mitacs; University of Calgary
First posted
Dec 1, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will compare the microbial and metabolomics analysis from the sample collected with the capsule series, to same-participant symptom questionnaires and stool microbial analysis.

Conditions

  • Irritable Bowel Syndrome
  • Crohn Disease
  • Celiac Disease
  • Ulcerative Colitis
  • Functional Dyspepsia
  • Type 2 Diabetes
  • Healthy

Interventions

  • fluid biopsy capsuleDevice

    Collection of a fluid biopsy from the small intestine via ingestible capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlation of bacterial composition with gastrointestinal disease states as assessed by PLS-DA mapping.Time frame: baseline, pre-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nimble Science

    Calgary, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.